Molecule Structure

Scientific Name

Lomustine

Description of the Drug

Lomustine is an alkylating agent used as a part of chemotherapeutic regimens for the treatment of primary and metastatic brain tumors as well as refractory or relapsed Hodgkin’s disease in addition to surgical and/or radiotherapeutic treatments.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01206

Brand Name(s)

Ccnu, Ceenu, Gleostine

Company Owner(s)

Corden Pharma Latina Spa

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
DNA NUCLEIC-ACID INHIBITOR CHEMBL2311221

Unichem Links

Atlas lomustine
SureChEMBL SCHEMBL3995
PharmGKB PA164749407
Human Metabolome Database HMDB0015337
DrugBank DB01206
PubChem: Thomson Pharma 15121730
PubChem 3950
Nikkaji J3.122D
BindingDB 50247919
EPA CompTox Dashboard DTXSID2023222
DrugCentral 1596
ChemicalBook CB5123021
Guide to Pharmacology 7214
rxnorm LOMUSTINE GLEOSTINE
KEGG Ligand C07079
ChEBI 6520
ZINC ZINC000003831006